concept

DOPAMINERGIC NEURONS

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about DOPAMINERGIC NEURONS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

643Connections

0Hypotheses

1Analyses

50Outgoing

50Incoming

0Experiments

No summary available yet. View on Wiki →

💡 Concept Info

Name	DOPAMINERGIC NEURONS
Key Genes/Proteins	ALPHA-SYNUCLEIN
Related Diseases	PARKINSON'S DISEASE
Related Pathways	DOPAMINE BIOSYNTHESIS, GLUCOCEREBROSIDES

Wiki Pages (20)

Knowledge base pages for this entity

Pathway Diagram

graph TD
    DOPAMINERGIC_NEURONS["DOPAMINERGIC NEURONS"]
    DOPAMINERGIC_NEURONS -->|"involved_in"| Parkinson_s_Disease["Parkinson's Disease"]
    DOPAMINERGIC_NEURONS -->|"expressed in"| SUBSTANTIA_NIGRA["SUBSTANTIA NIGRA"]
    DOPAMINERGIC_NEURONS -->|"activates"| NEURON["NEURON"]
    DOPAMINERGIC_NEURONS -->|"depletes"| PARKINSON_S_DISEASE["PARKINSON'S DISEASE"]
    DOPAMINERGIC_NEURONS -->|"activates"| MICROGLIA["MICROGLIA"]
    Parkinson_s_Disease -->|"causes"| DOPAMINERGIC_NEURONS
    ALPHA_SYNUCLEIN["ALPHA-SYNUCLEIN"] -->|"contributes to"| DOPAMINERGIC_NEURONS
    Emodin["Emodin"] -.protects against.-> DOPAMINERGIC_NEURONS
    PS_NPs["PS-NPs"] -->|"inhibits"| DOPAMINERGIC_NEURONS
    alpha_synuclein["alpha-synuclein"] -->|"causes"| DOPAMINERGIC_NEURONS
    Cellular_Senescence["Cellular Senescence"] -->|"expressed in"| DOPAMINERGIC_NEURONS
    Polystyrene_Nanoplastics["Polystyrene Nanoplastics"] -->|"targets"| DOPAMINERGIC_NEURONS

Outgoing (191)

Target	Relation	Type	Str
SUBSTANTIA NIGRA	depletes	brain_region	0.95
NEURON	activates	cell_type	0.95
NEURON	interacts_with	cell_type	0.95
PARKINSON'S DISEASE	depletes	disease	0.95
NEURON	contributes_to	cell_type	0.95
MICROGLIA	activates	cell_type	0.95
SUBSTANTIA NIGRA	causes	brain_region	0.95
NEURODEGENERATION	activates	process	0.95
SUBSTANTIA NIGRA	expressed_in	entity	0.95
NEURON	inhibits	cell_type	0.80
NEURODEGENERATION	causes	process	0.80
PARKINSON'S DISEASE	activates	disease	0.80
PARKINSON'S DISEASE	contributes_to	disease	0.80
PARKINSON'S DISEASE	protects_against	disease	0.65
PARKINSON'S DISEASE	regulates	disease	0.65
NEURON	implicated_in	cell_type	0.65
NEURON	depletes	cell_type	0.65
NEURON	expressed_in	cell_type	0.65
INFLAMMATION	activates	process	0.65
SUBSTANTIA NIGRA	contributes_to	brain_region	0.65
NEURON	causes	cell_type	0.65
PARKINSON'S DISEASE	interacts_with	disease	0.65
STRIATUM	activates	brain_region	0.65
NEURODEGENERATION	associated_with	process	0.65
SUBSTANTIA NIGRA	activates	brain_region	0.65
VENTRAL TEGMENTAL AREA	activates	brain_region	0.65
STEM CELLS	activates	cell_type	0.65
LRRK2	interacts_with	gene	0.65
PARKINSON'S DISEASE	inhibits	disease	0.50
SUBSTANTIA NIGRA	inhibits	brain_region	0.50
NEUROINFLAMMATION	implicated_in	process	0.50
NEURODEGENERATION	inhibits	process	0.50
PARKINSON'S DISEASE	implicated_in	disease	0.50
INFLAMMASOME	activates	protein	0.50
NEURODEGENERATION	implicated_in	process	0.50
SUBSTANTIA NIGRA	implicated_in	brain_region	0.50
NEUROINFLAMMATION	contributes_to	process	0.50
PARKINSON'S DISEASE	expressed_in	disease	0.50
NEUROINFLAMMATION	causes	process	0.50
NEURON	protects_against	cell_type	0.50
STRIATUM	depletes	brain_region	0.50
IPSC	activates	cell_type	0.50
NEUROINFLAMMATION	associated_with	process	0.50
NEUROINFLAMMATION	activates	process	0.50
IPSC	interacts_with	cell_type	0.50
LRRK2	activates	gene	0.50
FRONTAL CORTEX	associated_with	brain_region	0.50
CORTEX	associated_with	brain_region	0.50
AMPK SIGNALING	associated_with	pathway	0.50
WHITE MATTER	associated_with	brain_region	0.50

Incoming (452)

Source	Relation	Type	Str
ALPHA-SYNUCLEIN	contributes_to	gene	0.95
CELLULAR SENESCENCE	associated_with	entity	0.95
DOPAMINE BIOSYNTHESIS	expressed_in	pathway	0.90
GLUCOCEREBROSIDES	causes	biological_process	0.85
ALPHA-SYNUCLEIN	depletes	gene	0.80
LRRK2	expressed_in	gene	0.80
TRANSFERRIN RECEPTOR 1	involved_in	entity	0.80
TET2	stabilizes	gene	0.70
SUBSTANTIA NIGRA	stabilizes	brain_region	0.70
DOPAMINE	targets	phenotype	0.65
APOPTOSIS	inhibits	phenotype	0.65
PARKINSON'S DISEASE	degrades	disease	0.65
LRRK2	treats	gene	0.65
TH	targets	gene	0.65
ASTROCYTE	stabilizes	cell_type	0.65
PARKINSON'S DISEASE	stabilizes	disease	0.65
LRRK2	inhibits	gene	0.65
LRRK2	causes	gene	0.65
AKT	protects_against	gene	0.65
JAK/STAT PATHWAY	protects_against	pathway	0.65
AMYLOID	activates	protein	0.65
PARKINSON'S DISEASE	activates	disease	0.65
NLRP3 INFLAMMASOME	treats	pathway	0.65
CTSB	activates	gene	0.65
MITOPHAGY	regulates	phenotype	0.65
OXIDATIVE STRESS	activates	phenotype	0.65
AGING	interacts_with	phenotype	0.65
TH	inhibits	gene	0.65
GDNF	treats	gene	0.65
PARKINSON'S DISEASE	destabilizes	disease	0.60
CYP46A1	expressed_in	gene	0.55
MITOCHONDRIAL DYSFUNCTION	participates_in	phenotype	0.55
LRRK2	participates_in	gene	0.55
CHCHD10	expressed_in	gene	0.55
TH	depleted_in	gene	0.55
MITOCHONDRIAL DYSFUNCTION	implicated_in	phenotype	0.55
AUTOPHAGY	regulates	process	0.50
ALPHA-SYNUCLEIN	regulates	gene	0.50
ALPHA-SYNUCLEIN	activates	gene	0.50
BDNF	activates	gene	0.50
ALPHA-SYNUCLEIN	interacts_with	gene	0.50
ASTROCYTES	activates	cell_type	0.50
MITOCHONDRIA	associated_with	cell_type	0.50
NEURONS	associated_with	concept	0.50
DOPAMINERGIC	associated_with	concept	0.50
Neuron	causes	cell_type	0.50
NEURONS	causes	concept	0.50
DOPAMINERGIC	causes	concept	0.50
Cellular Senescence	causes	cell_type	0.50
Neuron	associated_with	cell_type	0.50

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

How does PSEN2 mechanistically regulate α-synuclein expression and pathology in

neurodegeneration | 2026-04-13 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

DOPAMINERGIC NEURONS

Understanding Entity Pages

Wiki Pages (20)

cbs-psp-daily-action-plan

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

Progressive Supranuclear Palsy (PSP)

Corticobasal Syndrome (CBS)

Novel Therapy Index

Parkinson's Disease

CBS/PSP Supplements Guide

Atypical Parkinsonism

Parthanatos in Neurodegeneration

calcium-dysregulation-comparison

Alpha-Synuclein Pathology

PD Combination Therapy Matrix

Corticobasal Degeneration (CBD)

nhp-validation-animal-model

NPM1 Gene

Neurons — Cell Type Hierarchy

neuroinflammation

CBS/PSP Treatment Rankings

GRIA3 Gene

NRF2 Oxidative Stress Pathway